| 1 |
王建,陈秋霞,王海燕,等. 广州市市售牡蛎诺如病毒污染情况分析[J]. 华南预防医学, 2022, 48(8): 981-984.
|
| 2 |
易中恒, 杨俊杰, 李薇. 诺如病毒感染的疾病负担及防治[J]. 微生物学免疫学进展, 2022, 50(3): 98-103.
|
| 3 |
刘小平, 宋永胜, 乌云桑. 一起诺如病毒引起的学校感染性腹泻暴发调查[J]. 中国卫生检验杂志, 2022, 32(5): 625-627, 631.
|
| 4 |
梁耀民, 陆胤波, 曹颖雯, 等. 诺如病毒和肠道菌群的互作关系及机制研究进展[J]. 病毒学报, 2021, 37(5): 1215-1220.
|
| 5 |
廖颖茵, 薛亮, 高珺珊, 等. 诺如病毒分子结构特征及其衣壳蛋白功能研究进展[J]. 病毒学报, 2021, 37(2): 459-464.
|
| 6 |
张静, 常昭瑞, 孙军玲, 等. 我国诺如病毒感染性腹泻流行现状及防制措施建议[J]. 疾病监测, 2014, 29(7): 516-521.
|
| 7 |
ROBINSON C M, JESUDHASAN P R, PFEIFFER J K. Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus[J]. Cell host and microbe, 2014, 15(1): 36-46.
|
| 8 |
PEñA-GIL N, SANTISO-BELLóN C, GOZALBO-ROVIRA R, et al. The role of host glycobiology and gut microbiota in Rotavirus and Norovirus infection, an update[J]. Nternational journal of molecular sciences, 2021, 22(24): 13473.
|
| 9 |
MURAKAMI K, TENGE V R, KARANDIKAR U C, et al. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids[J]. Proceedings of the national academy of sciences of the United States of America, 2020, 117(3): 1700-1710.
|
| 10 |
JONES M K, WATANABE M, ZHU S, et al. Enteric bacteria promote human and mouse norovirus infection of B cells[J]. Science, 2014, 346(6210): 755-759.
|
| 11 |
BALDRIDGE M T, NICE T J, MCCUNE B T, et al. Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection[J]. Science, 2015, 347(6219): 266-269.
|
| 12 |
RUBIO-DEL-CAMPO A, COLL-MARQUéS J M, YEBRA M J, et al. Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics[J]. PloS one, 2014, 9(2): e89586.
|
| 13 |
LEI S, RAMESH A, TWITCHELL E, et al. High protective efficacy of probiotics and rice bran against human Norovirus infection and diarrhea in gnotobiotic pigs[J]. Frontiers in microbiology, 2016, 7: 1699.
|
| 14 |
LI Y, GAO J, XUE L, et al. Determination of antiviral mechanism of centenarian gut-derived limosilactobacillus fermentum against Norovirus[J]. Frontiers in nutrition, 2022, 9: 812623.
|
| 15 |
ATKINSON M A, BOWMAN M A, CAMPBELL L, et al. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes[J]. The journal of clinical investigation, 1994, 94(5): 2125-2129.
|
| 16 |
ZARGARI SAMANI O, MAHMOODNIA L, IZAD M, et al. Alteration in CD8+ T cell subsets in enterovirus-infected patients: An alarming factor for type 1 diabetes mellitus[J]. The Kaohsiung journal of medical sciences, 2018, 34(5): 274-280.
|
| 17 |
PATIN N V, PEñA-GONZALEZ A, HATT J K, et al. The role of the gut microbiome in resisting Norovirus infection as revealed by a human challenge study[J]. MBio, 2020, 11(6): e02634-20.
|
| 18 |
文海聆, 姚业科, 唐志林. 双歧杆菌乳杆菌三联活菌片辅助治疗诺如病毒性肠炎的临床效果分析[J]. 数理医药学杂志, 2020, 33(8): 1167-1169.
|
| 19 |
CANNON J L, SEABOLT M H, XU R, et al. Gut microbiome changes occurring with Norovirus infection and recovery in infants enrolled in a longitudinal birth cohort in Leon, Nicaragua[J]. Viruses, 2022, 14(7): 1395.
|
| 20 |
程如越, 李鸣, 黄承钰, 等. 双歧杆菌防治儿童过敏性疾病的研究进展[C]//中国营养学会,中国疾病预防控制中心营养与健康所, 农业部食品与营养发展研究所,中科院上海生科院营养科学研究所.中国营养学会第十三届全国营养科学大会暨全球华人营养科学家大会论文集, 2017: 74.
|
| 21 |
TARRIS G, DE ROUGEMONT A, CHARKAOUI M, et al. Enteric viruses and inflammatory bowel disease[J]. Viruses, 2021, 13(1): 104.
|
| 22 |
李涵博, 丛鑫, 段招军. GII.26型诺如病毒的组织血型抗原结合特征[J]. 病毒学报, 2021, 37(6): 1310-1316.
|
| 23 |
ALMAND E A, MOORE M D, OUTLAW J, et al. Human norovirus binding to select bacteria representative of the human gut microbiota [J]. PloS one, 2017, 12(3): e0173124.
|
| 24 |
CONG X, LI H B, SUN X M, et al. Functional and structural characterization of Norovirus GII.6 in recognizing histo-blood group antigens[J]. Virologica sinica, 2023, 38(1): 56-65.
|
| 25 |
KARST S M. Identification of a novel cellular target and a co-factor for norovirus infection-B cells & commensal bacteria[J]. Gut microbes, 2015, 6(4): 266-271.
|
| 26 |
OKA T, STOLTZFUS G T, ZHU C, et al. Attempts to grow human noroviruses, a sapovirus, and a bovine norovirus in vitro[J]. PloS one, 2018, 13(2): e0178157.
|
| 27 |
丛鑫. 诺如病毒与寡糖结合机制的研究[D]. 北京：中国疾病预防控制中心, 2019.
|
| 28 |
GRAU K R, ZHU S, PETERSON S T, et al. The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type Ⅲ interferon[J]. Nature microbiology, 2020, 5(1): 84-92.
|
| 29 |
LUCERO Y, MATSON D O, ASHKENAZI S, et al. Norovirus: Facts and reflections from past, present, and future[J]. Viruses, 2021, 13(12): 2399.
|
| 30 |
GRAZIANO V R, WEI J, WILEN C B. Norovirus attachment and entry[J]. Viruses, 2019, 11(6): 495.
|
| 31 |
INAGAKI T, MOSCHETTA A, LEE Y K, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor[J]. Proceedings of the national academy of sciences of the United States of America, 2006, 103(10): 3920-3925.
|
| 32 |
ZHANG Y, KAST-WOELBERN H R, EDWARDS P A. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation[J]. The journal of biological chemistry, 2003, 278(1): 104-110.
|
| 33 |
NICE T J, BALDRIDGE M T, MCCUNE B T, et al. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity[J]. Science, 2015, 347(6219): 269-273.
|
| 34 |
HASSAN E, BALDRIDGE M T. Norovirus encounters in the gut: Multifaceted interactions and disease outcomes[J]. Mucosal immunology, 2019, 12(6): 1259-1267.
|
| 35 |
ABT M C, OSBORNE L C, MONTICELLI L A, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity[J]. Immunity, 2012, 37(1): 158-170.
|
| 36 |
WALKER F C, BALDRIDGE M T. Interactions between noroviruses, the host, and the microbiota [J]. Current opinion in virology, 2019, 37: 1-9.
|
| 37 |
MORI K, KONISHI N, SUZUKI Y, et al. Comparison between patients with norovirus-related gastroenteritis and asymptomatic carriers with respect to distribution of antibody-complexed viral particles and intestinal flora[J]. Journal of medical virology, 2018, 90(12): 1882-1887.
|
| 38 |
STEYER A, MIČETIĆ-TURK D, FIJAN S. The efficacy of probiotics as antiviral agents for the treatment of rotavirus gastrointestinal infections in children: An updated overview of literature[J]. Microorganisms, 2022, 10(12): 2392.
|
| 39 |
LI D, BREIMAN A, LE PENDU J, et al. Anti-viral effect of Bifidobacterium adolescentis against Noroviruses[J]. Frontiers in microbiology, 2016, 7: 864.
|
| 40 |
ABOUBAKR H A, EL-BANNA A A, YOUSSEF M M, et al. Antiviral effects of lactococcus lactis on feline Calicivirus, a human Norovirus surrogate[J]. Food and environmental virology, 2014, 6(4): 282-289.
|